Featured Article

Gold prices sees little reaction after U.S. Q1 GDP falls 4.8%

Posted by Neils Christensen, Kitco News

on Wednesday, 29 April 2020 7:04

Despite some optimism at the start of the year, the U.S. economy saw weaker than expected economic activity in the first quarter of 2020 as the global economy was turned upside down to the COVID-19 Pandemic
Wednesday the first reading of U.S. Gross Domestic Product showed that the U.S. economic growth fell 4.8% in the first quarter. The data were weaker than…click for full article.

The “costliest claim ever”

Posted by Conseiller, Editorial Staff

on Tuesday, 28 April 2020 15:17

The challenge is huge for insurance companies.

The COVID-19 pandemic will be “the most costly event in history for the insurance industry” and represents “without a doubt the greatest challenge our industry has ever faced,” says the director. General of Lloyd’s of London, John Neal.

In an interview published Friday with the Financial Times , the leader judges that the coronavirus will cause “tens of billions, even hundreds of billions of dollars of damage”. As a result, he adds, the compensation paid to businesses and individuals will far exceed the roughly $ 50 billion that insurers had to pay after Hurricane Katrina …Click for full article.

Economy in Banff has ‘collapsed’ as COVID-19 wipes out tourism industry

Posted by Olivia Condon. Edmonton Journal

on Tuesday, 28 April 2020 15:09

In the nearly six weeks since declaring a state of local emergency and shuttering all non-essential businesses, the economy in Banff has been at a standstill.

Normally, tourists would be flocking in droves to the mountain destination — at this time last year, the town’s main concern was finding enough parking spots. Now, Banff streets are eerily quiet and RCMP checkstops occupy the two main entrances to town. “Our economy is basically 90 per cent based on tourism, directly and indirectly, so our town has ground to a halt. It’s a very serious… Click for full article.

PGM Update – ValOre Metals

Posted by Dustin Zinger

on Monday, 27 April 2020 13:29

A Deep Dive On Coronavirus Vaccine Plays Moderna, Inovio

Posted by Shanthi Rexaline

on Monday, 27 April 2020 10:24

Among the six coronavirus vaccine candidates that have entered human trials, two belong to publicly listed U.S. companies: Moderna Inc and Inovio Pharmaceuticals Inc Both stocks have rallied in reaction to updates on R&D and funding.

Moderna is up about 143% year-to-date and Inovio is higher by 265%.

Moderna, Inovio’s Vaccine Candidates

Both Moderna and Inovio use a modern approach as opposed to conventional vaccines that employ a weakened form of the pathogen, a killed pathogen or specific pieces of pathogen such as its protein, sugar or capsid.

Moderna is developing mRNA-1273, an mRNA vaccine, against the new coronavirus in collaboration with the Vaccine Research Center at the NIH’s National Institute of Allergy and Infectious Diseases. It is a vaccine against SARS-CoV-2 encoding for the spike, or S, protein….CLICK for complete article